Biodexa Pharmaceuticals Plc (BDRX) stock
BDRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 1/30
$2.04−0.10 (-4.89%)
Close on Nov 18, 2026Market cap $4.60MP/E –Yield –
Biodexa Pharmaceuticals revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2023 it was £381.00K, down 45.5% from the year before. The highest annual figure on record is £1.94M in fiscal 2018.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | £381.00K | -45.5% |
| FY2022 | Dec 31, 2022 | £699.00K | +20.9% |
| FY2021 | Dec 31, 2021 | £578.00K | +68.5% |
| FY2020 | Dec 31, 2020 | £343.00K | -49.1% |
| FY2019 | Dec 31, 2019 | £674.00K | -65.2% |
| FY2018 | Dec 31, 2018 | £1.94M | +96.0% |
| FY2017 | Dec 31, 2017 | £989.00K | -25.2% |
| FY2016 | Dec 31, 2016 | £1.32M | -3.8% |
| FY2015 | Dec 31, 2015 | £1.38M | – |
See a number that looks wrong?